Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTFC vs DTFC add-on to prostaglandin analogs in open angle glaucoma or ocular hypertension
jRCTs051190125Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of brimonidine tartrate + timolol maleate in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Senju Pharmaceutical Co., Ltd. Primary endpoint: Change in intraocular pressure (average of hour 0 and hour 2). Started Apr 2020; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCTs051190125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190125.